D. Cominetti

发表

Improved Apoptotic Cell Death in Drug-Resistant Non–Small-Cell Lung Cancer Cells by Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Based Treatment

N. Zaffaroni, F. Zunino, P. Perego, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Improved apoptotic cell death in drug-resistant non small cell lung cancer cells by TRAIL-based treatment

N. Zaffaroni, F. Zunino, P. Perego, 2013 .

New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation.

F. Zunino, V. Zuco, Laura Muzi, 2015, Bioorganic & medicinal chemistry.

Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases.

N. Zaffaroni, E. Favini, C. Lanzi, 2018, Cancer letters.

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.

A. D. Dei Tos, P. Casali, T. Negri, 2017, European journal of cancer.

miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression

N. Zaffaroni, R. Valdagni, V. Zuco, 2020, Cells.

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.

A. D. Dei Tos, P. Casali, T. Negri, 2014, European journal of cancer.

The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.

N. Zaffaroni, F. Zunino, C. Lanzi, 2012, Biochemical pharmacology.

Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models.

N. Zaffaroni, F. Zunino, E. Favini, 2013, Biochemical pharmacology.

[1,2]Oxazolo[5,4-e]isoindoles as promising tubulin polymerization inhibitors.

N. Zaffaroni, M. Pennati, P. Diana, 2016, European journal of medicinal chemistry.

Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma.

N. Zaffaroni, M. Pennati, P. Diana, 2016, Journal of medicinal chemistry.

Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft

M. Gounder, A. D. Dei Tos, P. Casali, 2019, Cancers.

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin

N. Zaffaroni, M. Pennati, M. de Cesare, 2015, Oncotarget.

Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma.

F. Vasile, D. Potenza, L. Belvisi, 2014, Molecular pharmaceutics.

miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis.

Claudio Stucchi, Tiziana Rancati, M. Dugo, 2017, Cancer letters.

Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

M. Borrello, N. Zaffaroni, E. Favini, 2014, The Journal of clinical endocrinology and metabolism.

Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics

C. Morosi, P. Casali, T. Negri, 2013, Clinical Cancer Research.

Synergistic Antitumor Activity of Cetuximab and Namitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High EGFR Gene Copy Number

N. Zaffaroni, F. Zunino, S. Veronese, 2013, Clinical Cancer Research.

Maspin influences response to doxorubicin by changing the tumor microenvironment organization

M. Carcangiu, E. Tagliabue, P. Casalini, 2014, International journal of cancer.

Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

C. Tripodo, N. Zaffaroni, F. Zunino, 2018, Hematological oncology.

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

N. Zaffaroni, P. Perego, N. Carenini, 2014, Oncotarget.

Cancer Therapy : Preclinical SynergisticAntitumorActivityofCetuximabandNamitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High EGFR Gene Copy Number

N. Zaffaroni, F. Zunino, S. Veronese, 2014 .

Targeting the invasive phenotype of cisplatin-resistant non-small cell lung cancer cells by a novel histone deacetylase inhibitor.

G. Giannini, N. Zaffaroni, F. Zunino, 2015, Biochemical pharmacology.

Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models.

E. Favini, C. Lanzi, G. Cassinelli, 2013, Biochemical pharmacology.